Skip to main content
Top
Published in: Clinical Oral Investigations 5/2019

01-05-2019 | Original Article

Screening and diagnosis of oral cancer: a critical quality appraisal of clinical guidelines

Authors: Meisser Madera, Juan Franco, Ivan Solà, Xavier Bonfill, Pablo Alonso-Coello

Published in: Clinical Oral Investigations | Issue 5/2019

Login to get access

Abstract

Objectives

To assess the quality of clinical practice guidelines (CPGs) on screening and diagnosis of oral cancer and to describe the characteristics of their recommendations.

Materials and methods

We systematically searched EMBASE, MEDLINE, CPG’ websites, and dentistry and oncology scientific societies to identify CPGs that were related to screening and diagnosis of oral cancer. The quality of selected CPGs was independently assessed by four appraisers using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument. The inter-appraiser agreement was assessed. We performed a descriptive analysis of the recommendations included in the selected CPGs.

Results

Eight CPGs were selected. The overall agreement among reviewers was considered very good (ICC: 0.823; 95% CI: 0.777–0.861). The median scores of the six AGREE II domains were as follows: “scope and purpose” 97.9% (IQR: 96.2–100.0%); “stakeholder involvement” 86.1% (IQR: 69.8–93.1%); “rigor of development” 75.3% (IQR: 64.2–94.3%); “clarity of presentation” 91.7% (IQR: 82.6–94.4%); “applicability” 53.1% (IQR: 19.3–74.2%); and “editorial independence” 83.3% (IQR: 67.2–93.8%). Four CPGs were assessed as “recommended”, four “recommended with modifications”, and none “not recommended”. Twenty-three recommendations were provided, mostly with a low or very low level of evidence.

Conclusion

The methodological quality of CPGs on screening and diagnosis of oral cancer is moderate. The “applicability” domain scored the lowest. Most recommendations were based on a low o very low level of evidence.

Clinical relevance

Greater efforts are needed to provide healthcare based on high-quality evidence-based CPGs in this field.
Appendix
Available only for authorised users
Literature
2.
go back to reference Chen YP, Wang YQ, Li WF, Chen L, Xu C, Lu TX, Lin AH, Yao JJ, Li YC, Sun Y, Mao YP, Ma J (2017) Critical evaluation of the quality and recommendations of clinical practice guidelines for nasopharyngeal carcinoma. J Natl Compr Cancer Netw 15(3):336–344CrossRef Chen YP, Wang YQ, Li WF, Chen L, Xu C, Lu TX, Lin AH, Yao JJ, Li YC, Sun Y, Mao YP, Ma J (2017) Critical evaluation of the quality and recommendations of clinical practice guidelines for nasopharyngeal carcinoma. J Natl Compr Cancer Netw 15(3):336–344CrossRef
3.
go back to reference Eslava-Schmalbach J, Sandoval-Vargas G, Mosquera P (2011) Incorporating equity into developing and implementing for evidence-based clinical practice guidelines. Rev Salud Publica (Bogota) 13(2):339–351CrossRef Eslava-Schmalbach J, Sandoval-Vargas G, Mosquera P (2011) Incorporating equity into developing and implementing for evidence-based clinical practice guidelines. Rev Salud Publica (Bogota) 13(2):339–351CrossRef
5.
go back to reference Graham ID, Beardall S, Carter AO, Glennie J, Hebert PC, Tetroe JM, McAlister FA, Visentin S, Anderson GM (2001) What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ 165(2):157–163PubMedPubMedCentral Graham ID, Beardall S, Carter AO, Glennie J, Hebert PC, Tetroe JM, McAlister FA, Visentin S, Anderson GM (2001) What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ 165(2):157–163PubMedPubMedCentral
12.
go back to reference Costa K, Cunha K, Rodrigues F, Silva L, Dias E (2013) Concordance between cytopathology and incisional biopsy in the diagnosis of oral squamous cell carcinoma. Braz Oral Res 27(2):122–127CrossRef Costa K, Cunha K, Rodrigues F, Silva L, Dias E (2013) Concordance between cytopathology and incisional biopsy in the diagnosis of oral squamous cell carcinoma. Braz Oral Res 27(2):122–127CrossRef
16.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed
20.
go back to reference Grégoire V, Leroy R, Heus P, Van de Wetering F, Hooft L, Scholten R, Verleye L, Carp L, Clement P, Deron P, Goffin K, Hamoir M, Hauben E, Hendrickx K, Hermans R, Kunz S, Lenssen O, Nuyts S, Van Laer C, Vermorken J, Appermont E, De Prins A, Hebbelinck E, Hommez G, Vandenbruaene C, Vanhalewyck E, Vlayen J (2014) Oral cavity cancer: diagnosis, treatment and follow-up. Good Clinical Practice (GCP). Belgian Health Care Knowledge Centre (KCE), Brussels KCE Reports 227 Grégoire V, Leroy R, Heus P, Van de Wetering F, Hooft L, Scholten R, Verleye L, Carp L, Clement P, Deron P, Goffin K, Hamoir M, Hauben E, Hendrickx K, Hermans R, Kunz S, Lenssen O, Nuyts S, Van Laer C, Vermorken J, Appermont E, De Prins A, Hebbelinck E, Hommez G, Vandenbruaene C, Vanhalewyck E, Vlayen J (2014) Oral cavity cancer: diagnosis, treatment and follow-up. Good Clinical Practice (GCP). Belgian Health Care Knowledge Centre (KCE), Brussels KCE Reports 227
21.
go back to reference Lingen MW, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D'Souza G, Gurenlian J, Kalmar JR, Kerr AR, Lambert PM, Patton LL, Sollecito TP, Truelove E, Tampi MP, Urquhart O, Banfield L, Carrasco-Labra A (2017) Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American dental association. J Am Dent Assoc 148(10):712–727 e710. https://doi.org/10.1016/j.adaj.2017.07.032 CrossRefPubMed Lingen MW, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D'Souza G, Gurenlian J, Kalmar JR, Kerr AR, Lambert PM, Patton LL, Sollecito TP, Truelove E, Tampi MP, Urquhart O, Banfield L, Carrasco-Labra A (2017) Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American dental association. J Am Dent Assoc 148(10):712–727 e710. https://​doi.​org/​10.​1016/​j.​adaj.​2017.​07.​032 CrossRefPubMed
23.
go back to reference NICE (2015) NICE Guideline. In: Suspected Cancer: Recognition and Referral. National Institute for Health and Care Excellence: Clinical Guidelines, London, pp 1–378 NICE (2015) NICE Guideline. In: Suspected Cancer: Recognition and Referral. National Institute for Health and Care Excellence: Clinical Guidelines, London, pp 1–378
25.
go back to reference Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, Grimshaw JM, Woolf SH (2001) Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? Jama 286(12):1461–1467CrossRefPubMed Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, Grimshaw JM, Woolf SH (2001) Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? Jama 286(12):1461–1467CrossRefPubMed
27.
go back to reference Jiang Y, Zhu XD, Qu S, Li L, Zhou Z (2015) Guidelines for squamous cell carcinoma of the head and neck: a systematic assessment of quality. Ear Nose Throat J 94(4–5):E14–E24PubMed Jiang Y, Zhu XD, Qu S, Li L, Zhou Z (2015) Guidelines for squamous cell carcinoma of the head and neck: a systematic assessment of quality. Ear Nose Throat J 94(4–5):E14–E24PubMed
28.
37.
go back to reference Alonso-Coello P, Schunemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Rada G, Rosenbaum S, Morelli A, Guyatt GH, Oxman AD (2016) GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction. BMJ 353:i2016. https://doi.org/10.1136/bmj.i2016 CrossRefPubMed Alonso-Coello P, Schunemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Rada G, Rosenbaum S, Morelli A, Guyatt GH, Oxman AD (2016) GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction. BMJ 353:i2016. https://​doi.​org/​10.​1136/​bmj.​i2016 CrossRefPubMed
38.
go back to reference BDA (2010) Early detection and prevention of oral cancer: a management strategy for dental practice. The British Dental Association-Occasional paper, pp 1–37 BDA (2010) Early detection and prevention of oral cancer: a management strategy for dental practice. The British Dental Association-Occasional paper, pp 1–37
40.
go back to reference RACGP (2012) The Royal Australian College of General Practitioner. Early detection of cancers. Guidelines for preventive activities in general practice ('the red book') 8th edition: 68. https://www.racgp.org.au. Accessed 28 Jan 2018 RACGP (2012) The Royal Australian College of General Practitioner. Early detection of cancers. Guidelines for preventive activities in general practice ('the red book') 8th edition: 68. https://​www.​racgp.​org.​au. Accessed 28 Jan 2018
41.
go back to reference AHNCWG (2013) Australian Head and Neck Cancer Working Group. South Australian Head and Neck Cancer Pathway: Optimising outcomes for all South Australians diagnosed: 1–146. http://www.sahealth.sa.gov.au. Accessed 28 Jan 2018 AHNCWG (2013) Australian Head and Neck Cancer Working Group. South Australian Head and Neck Cancer Pathway: Optimising outcomes for all South Australians diagnosed: 1–146. http://​www.​sahealth.​sa.​gov.​au. Accessed 28 Jan 2018
Metadata
Title
Screening and diagnosis of oral cancer: a critical quality appraisal of clinical guidelines
Authors
Meisser Madera
Juan Franco
Ivan Solà
Xavier Bonfill
Pablo Alonso-Coello
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
Clinical Oral Investigations / Issue 5/2019
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-018-2668-7

Other articles of this Issue 5/2019

Clinical Oral Investigations 5/2019 Go to the issue